(MedPage Today) -- All lots of the new anemia drug peginesatide (Omontys) have been recalled because of severe hypersensitivity reactions -- some fatal -- observed after the drug was approved last March. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment